Skip to Main Content

Paper Details

A genetic model for central chondrosarcoma evolution correlates with patient outcome.
Genome Med
6
2022
CS, IDH, IDH wild-type tumours, IDH1, IDH1-, IDH2, IDH2 mutations, IDH2-mutant, IDH2-mutant tumours, IDHwt, TERT, TERT mutations, TERT promoter, Tumours, central chondrosarcoma, conventional chondrosarcoma, methylation array, patient, patients, primary malignant bone tumour, tumours
Author NameAffiliation
Fernanda AmaryRoyal National Orthopaedic Hospital
Fernanda AmaryRoyal National Orthopaedic Hospital
Roberto TiraboscoRoyal National Orthopaedic Hospital
Roberto TiraboscoRoyal National Orthopaedic Hospital
Christopher J SteeleUniversity College London, UCL Cancer Institute
Ludmil B AlexandrovUniversity of California
Ludmil B AlexandrovUniversity of California
Peter Van LooThe Francis Crick Institute
Adrienne M FlanaganUniversity College London, UCL Cancer Institute
Adrienne M FlanaganRoyal National Orthopaedic Hospital
Adrienne M FlanaganUniversity College London, UCL Cancer Institute
Adrienne M FlanaganRoyal National Orthopaedic Hospital
  • 1 - 12

Datasets

Release 1.2